chrX-123886431-C-G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001167.4(XIAP):ā€‹c.769C>Gā€‹(p.Pro257Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,209,593 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 571 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00072 ( 0 hom., 15 hem., cov: 23)
Exomes š‘“: 0.0015 ( 0 hom. 556 hem. )

Consequence

XIAP
NM_001167.4 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 3.56
Variant links:
Genes affected
XIAP (HGNC:592): (X-linked inhibitor of apoptosis) This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03549859).
BP6
Variant X-123886431-C-G is Benign according to our data. Variant chrX-123886431-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 465073.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}. Variant chrX-123886431-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000722 (81/112159) while in subpopulation NFE AF= 0.00143 (76/53261). AF 95% confidence interval is 0.00117. There are 0 homozygotes in gnomad4. There are 15 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 15 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
XIAPNM_001167.4 linkc.769C>G p.Pro257Ala missense_variant 2/7 ENST00000371199.8 NP_001158.2 P98170

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
XIAPENST00000371199.8 linkc.769C>G p.Pro257Ala missense_variant 2/71 NM_001167.4 ENSP00000360242.3 P98170

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
81
AN:
112104
Hom.:
0
Cov.:
23
AF XY:
0.000438
AC XY:
15
AN XY:
34260
show subpopulations
Gnomad AFR
AF:
0.0000648
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000192
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00143
Gnomad OTH
AF:
0.000663
GnomAD3 exomes
AF:
0.000674
AC:
123
AN:
182389
Hom.:
0
AF XY:
0.000657
AC XY:
44
AN XY:
66983
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.0000729
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000133
Gnomad NFE exome
AF:
0.00141
Gnomad OTH exome
AF:
0.000664
GnomAD4 exome
AF:
0.00152
AC:
1670
AN:
1097434
Hom.:
0
Cov.:
31
AF XY:
0.00153
AC XY:
556
AN XY:
362942
show subpopulations
Gnomad4 AFR exome
AF:
0.000189
Gnomad4 AMR exome
AF:
0.0000852
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000327
Gnomad4 NFE exome
AF:
0.00191
Gnomad4 OTH exome
AF:
0.000803
GnomAD4 genome
AF:
0.000722
AC:
81
AN:
112159
Hom.:
0
Cov.:
23
AF XY:
0.000437
AC XY:
15
AN XY:
34325
show subpopulations
Gnomad4 AFR
AF:
0.0000647
Gnomad4 AMR
AF:
0.000192
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00143
Gnomad4 OTH
AF:
0.000655
Alfa
AF:
0.00125
Hom.:
21
Bravo
AF:
0.000880
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00277
AC:
8
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00208
AC:
14
ExAC
AF:
0.000782
AC:
95
EpiCase
AF:
0.00158
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

X-linked lymphoproliferative disease due to XIAP deficiency Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 03, 2025- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 28, 2018- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Autoinflammatory syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMar 30, 2022- -
XIAP-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 13, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
21
DANN
Benign
0.93
DEOGEN2
Benign
0.29
T;T;T
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.73
T;.;.
M_CAP
Benign
0.0082
T
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.4
M;M;M
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.3
N;N;N
REVEL
Benign
0.091
Sift
Uncertain
0.021
D;D;D
Sift4G
Benign
0.29
T;T;T
Polyphen
0.56
P;P;P
Vest4
0.49
MVP
0.21
MPC
0.22
ClinPred
0.063
T
GERP RS
4.9
Varity_R
0.24
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138783302; hg19: chrX-123020281; API